Surplus Pharma Stock Ahmedabad — Gujarat's Pharma Dead Stock Exchange

Ahmedabad's Pharmaceutical Surplus Market

Gujarat is India's pharmaceutical capital — producing over 35% of India's total pharma output and more than 28% of its pharma exports. Ahmedabad sits at the centre of this industry, hosting hundreds of API manufacturers, formulation companies, and packaging suppliers across Vatva, Narol, Odhav, and the Ahmedabad–Anand pharma corridor.

This density means Ahmedabad generates substantial surplus pharma stock — cancelled export batches, near-expiry API lots, discontinued formulations, and excess packaging — on a continuous basis. LeftLot, headquartered in Ahmedabad, is the natural marketplace for this inventory.

LeftLot's Home-Ground Advantage in Ahmedabad Pharma

As a Gujarat-headquartered company, LeftLot has local knowledge of Ahmedabad's pharma ecosystem that national platforms lack. Our team understands the Gujarat pharma supply chain, the documentation norms of local manufacturers, and the buyer-seller dynamics of the GIDC clusters.

For complex pharma dead stock lots — large API batches, multi-SKU formulation clearances, or regulated substance surplus — our Ahmedabad team provides on-the-ground support with documentation, photography, and lot preparation that remote platforms cannot offer.

What Ahmedabad Pharma Surplus Can Be Listed

• API surplus — Ahmedabad manufactures a wide range of APIs including antibiotics, cardiovasculars, and antivirals
• Formulations — branded and generic tablets, capsules, injectables, syrups
• Nutraceuticals and OTC products from Gujarat's supplement manufacturing cluster
• Pharmaceutical packaging — bottles, blister material, cartons, labels
• Drug intermediates and starting materials
• Lab chemicals and reagents from pharma R&D units